Tissue inhibitor of metalloproteinase-1 mRNA production and protein secretion are induced by interleukin-1β in 3T3-L1 adipocytes

Journal of Endocrinology

Volumn 198, Issue 1, 2008, Pages 169-174

  Weise, Sebastian ^a   Kralisch, Susan ^a,b   Sommer, Grit ^a   Lossner, Ulrike ^a   Bluher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; JANUS KINASE 2; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN RESISTANCE; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION;

3T3-L1 CELLS; ANIMALS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47849089771     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-07-0631     Document Type: Article

References (23)

1. Alexander CM, Selvarajan S, Mudgett J & Werb Z 2001 Stromelysin-1 regulates adipogenesis during mammary gland involution. Journal of Cell Biology 152 693-703.
2. Barksby HE, Lea SR, Preshaw PM & Taylor JJ 2007 The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clinical and Experimental Immunology 149 217-225.
3. Beaudeux JL, Giral P, Bruckert E, Bernard M, Foglietti MJ & Chapman MJ 2003 Serum matrix metalloproteinase-3 and tissue inhibitor of metallo-proteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis 169 139-146.
4. Cao Z, Henzel WJ & Gao X 1996 IRAK: a kinase associated with the interleukin-1 receptor. Science 271 1128-1131.
5. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E & Tartare-Deckert S 2003 Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. Journal of Biological Chemistry 278 11888-11896.
6. Crandall DL, Hausman GJ & Kral JG 1997 A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4 211-232.
7. Dinarello CA 1997 Interieukin-1. Cytokine and Growth Factor Reviews 8 253-265.
8. Doi M, Shichiri M, Katsuyama K, Ishimaru S & Hirata Y 2002 Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent frorn NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis 160 123-132.
9. Fasshauer M & Paschke R 2003 Regulation of adipocytokines and insulin resistance. Diabetologia 46 1594-1603.
10. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J & Paschke R 2004 Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor - and Jak/Stat signaling pathways in 3T3-L1 adipocytes. Journal of Endocrinology 181 129-138.
11. He J, Usui I, Ishizuka K, Kanatani Y, Hiratani K, Iwata M, Bukhari A, Haruta T, Sasaoka T & Kobayashi M 2006 Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Molecular Endocrinology 20 114-124.
12. Jager J, Gremeaux T, Cormont M, Marchand-BTUStel Y & Tanti JF 2007 Interleukin-1beca-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148 241-251.
13. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M & Fasshauer M 2005 Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes. FEBS Letters 579 6417-6422.
14. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M & Fasshauer M 2006 TIMP-1 expression and secretion are induced by β-adrenergic stimulation in 3T3-L1 adipocytes. Journal of Endocrinology 189 665-670.
15. Kralisch S, Bluher M, Tonjes A, Lossner U, Paschke R, Stumvoll M & Fasshauer M 2007 Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. European Journal of Endocrinology 156 257-261.
16. Laborda J 1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Research 19 3998.
17. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J & Caron M 2006 Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49 2162-2173.
18. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T & Donath MY 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus. New England Journal of Medicine 356 1517-1526.
19. Lijnen HR, Demeulemeester D, Van Hoef B, Collen D & Maquoi E 2003 Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thrombosis and Haemostasis 89 249-255.
20. Maquoi E, Munaut C, Colige A, Collen D & Lijnen HR 2002 Modulation of adipose tissue expression ofmurine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51 1093-1101.
21. Reddy SA, Huang JH & Liao WS 1997 Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. Journal of Biological Chemistry 272 29167-29173.
22. Stylianou E & Saklatvala J 1998 Interleukin-1. International Journal of Biochemistry and Cell Biology 30 1075-1079.
23. Thomas HE, Irawaty W, Darwiche R, Brodnicki TC, Santamaria P, Allison J & Kay TW 2004 IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 53 113-121.